Cargando…
Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
Natural killer (NK) cells have an intrinsic ability to detect and eliminate leukaemic cells. Cellular therapies using cytokine-activated NK cells have emerged as promising treatments for patients with advanced leukaemia. However, not all patients respond to current NK cell therapies, and thus improv...
Autores principales: | Barnes, Samantha A., Audsley, Katherine M., Newnes, Hannah V., Fernandez, Sonia, de Jong, Emma, Waithman, Jason, Foley, Bree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731670/ https://www.ncbi.nlm.nih.gov/pubmed/36505400 http://dx.doi.org/10.3389/fimmu.2022.1050718 |
Ejemplares similares
-
Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020) -
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
por: Buzzai, Anthony C., et al.
Publicado: (2020) -
Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021) -
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
por: Audsley, Katherine M., et al.
Publicado: (2021) -
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
por: Barrett, Lucy W, et al.
Publicado: (2022)